Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
548 INR | -0.20% | +3.18% | +29.14% |
04-03 | Wockhardt Limited Announces Cessation of Independent Directors | CI |
02-14 | Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Sales 2022 | 32.3B 387M 527M | Sales 2023 | 26.51B 318M 433M | Capitalization | 22.18B 266M 362M |
---|---|---|---|---|---|
Net income 2022 | -2.44B -29.24M -39.83M | Net income 2023 | -5.59B -66.99M -91.26M | EV / Sales 2022 | 1.74 x |
Net Debt 2022 | 18.16B 218M 296M | Net Debt 2023 | 20.68B 248M 338M | EV / Sales 2023 | 1.62 x |
P/E ratio 2022 |
-13
x | P/E ratio 2023 |
-3.97
x | Employees | 2,740 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.31% |
1 day | -0.20% | ||
1 week | +3.18% | ||
Current month | -3.26% | ||
1 month | -4.35% | ||
3 months | -0.66% | ||
6 months | +67.87% | ||
Current year | +29.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 09-03-31 | |
Founder | 81 | 66-12-31 | |
Deepak Madnani
DFI | Director of Finance/CFO | - | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 81 | 66-12-31 | |
Director/Board Member | 71 | 20-08-28 | |
Chief Executive Officer | 51 | 09-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +5.51% | - | |
0.00% | 34 M€ | +4.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 548 | -0.20% | 35 531 |
24-05-16 | 549.1 | +0.98% | 117,335 |
24-05-15 | 543.8 | -1.03% | 102,447 |
24-05-14 | 549.4 | +2.32% | 219,239 |
24-05-13 | 537 | +1.10% | 296,178 |
Delayed Quote NSE India S.E., May 17, 2024 at 02:05 am
More quotes1st Jan change | Capi. | |
---|---|---|
+29.14% | 1.01B | |
+21.43% | 44.15B | |
+23.03% | 23.02B | |
+19.25% | 15.33B | |
+12.96% | 13.74B | |
+49.93% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- WOCKPHARMA Stock